Articaine Hydrochloride
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB09009 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | gout | KG + DL |
| 2 | exostosis | KG + DL |
| 3 | allergic asthma | KG + DL |
| 4 | intrinsic asthma | KG + DL |
| 5 | exostoses, multiple, | KG + DL |
| 6 | hypotrichosis simplex of the scalp | KG + DL |
| 7 | alopecia | KG + DL |
| 8 | autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | KG + DL |
| 9 | brain small vessel disease 1 with or without ocular anomalies | KG + DL |
| 10 | congenital hypotrichosis milia | KG + DL |
| 11 | diabetic nephropathy | KG + DL |
| 12 | osteoarthritis susceptibility | KG + DL |
| 13 | diffuse alopecia areata | KG + DL |
| 14 | asthma-related traits, susceptibility to | KG + DL |
| 15 | osteoarthritis | KG + DL |
| 16 | asthma | KG + DL |
| 17 | congestive heart failure | KG + DL |
| 18 | anaphylaxis | KG + DL |
| 19 | disorder of O-xylosylglycan synthesis | KG + DL |
| 20 | acute pulmonary heart disease | KG + DL |
| 21 | acromesomelic dysplasia, Hunter-Thompson type | KG + DL |
| 22 | Raynaud disease | KG + DL |
| 23 | fetal erythroblastosis | KG + DL |
| 24 | chronic kidney disease | KG + DL |
| 25 | renin-angiotensin-aldosterone system-blocker-induced angioedema | KG + DL |
| 26 | idiopathic granulomatous myositis | KG + DL |
| 27 | myositis fibrosa | KG + DL |
| 28 | tendinitis | KG + DL |
| 29 | cough variant asthma | KG + DL |
| 30 | food-dependent exercise-induced anaphylaxis | KG + DL |
| 31 | pseudoachondroplasia | KG + DL |
| 32 | bronchitis | KG + DL |
| 33 | brachyolmia | KG + DL |
| 34 | iris disease | KG + DL |
| 35 | arthropathy | KG + DL |
| 36 | fibromyalgia | KG + DL |
| 37 | brachyolmia-amelogenesis imperfecta syndrome | KG + DL |
| 38 | end stage renal failure | KG + DL |
| 39 | myosclerosis | KG + DL |
| 40 | hypotrichosis of eyelid | KG + DL |
| 41 | chronic pulmonary heart disease | KG + DL |
| 42 | bronchial disease | KG + DL |
| 43 | inclusion body myositis | KG + DL |
| 44 | autoimmune oophoritis | KG + DL |
| 45 | type 1 diabetes mellitus | KG + DL |
| 46 | chronic renal failure syndrome | KG + DL |
| 47 | panuveitis (disease) | KG + DL |
| 48 | psoriasis | KG + DL |
| 49 | iris cancer | KG + DL |
| 50 | benign neoplasm of iris | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.